The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Non-Invasive Blood Glucose Monitoring System Market Research Report 2025
Synopsis
Global Non-Invasive Blood Glucose Monitoring System market is projected to reach US$ 83 million in 2029, increasing from US$ 20 million in 2022, with the CAGR of 8.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-Invasive Blood Glucose Monitoring System market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Non-Invasive Blood Glucose Monitoring System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
Medtronic plc
F. Hoffmann-La Roche Ltd.
Ascensia Diabetes Care
Dexcom, Inc.
Sanofi Novo Nordisk
Insulet Corporation
Ypsomed Holdings
Glysens Incorporated
Segment by Type
Wearable Blood Glucose Monitoring Systems
Non-wearable /Table-top Blood Glucose Monitoring Systems
Segment by Application
Hospitals
Homecare
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Non-Invasive Blood Glucose Monitoring System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Non-Invasive Blood Glucose Monitoring System market is projected to reach US$ 83 million in 2029, increasing from US$ 20 million in 2022, with the CAGR of 8.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-Invasive Blood Glucose Monitoring System market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Non-Invasive Blood Glucose Monitoring System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
Medtronic plc
F. Hoffmann-La Roche Ltd.
Ascensia Diabetes Care
Dexcom, Inc.
Sanofi Novo Nordisk
Insulet Corporation
Ypsomed Holdings
Glysens Incorporated
Segment by Type
Wearable Blood Glucose Monitoring Systems
Non-wearable /Table-top Blood Glucose Monitoring Systems
Segment by Application
Hospitals
Homecare
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Non-Invasive Blood Glucose Monitoring System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Non-Invasive Blood Glucose Monitoring System Market Overview
1.1 Product Overview and Scope of Non-Invasive Blood Glucose Monitoring System
1.2 Non-Invasive Blood Glucose Monitoring System Segment by Type
1.2.1 Global Non-Invasive Blood Glucose Monitoring System Market Value Comparison by Type (2023-2029)
1.2.2 Wearable Blood Glucose Monitoring Systems
1.2.3 Non-wearable /Table-top Blood Glucose Monitoring Systems
1.3 Non-Invasive Blood Glucose Monitoring System Segment by Application
1.3.1 Global Non-Invasive Blood Glucose Monitoring System Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Clinics
1.4 Global Non-Invasive Blood Glucose Monitoring System Market Size Estimates and Forecasts
1.4.1 Global Non-Invasive Blood Glucose Monitoring System Revenue 2018-2029
1.4.2 Global Non-Invasive Blood Glucose Monitoring System Sales 2018-2029
1.4.3 Global Non-Invasive Blood Glucose Monitoring System Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Non-Invasive Blood Glucose Monitoring System Market Competition by Manufacturers
2.1 Global Non-Invasive Blood Glucose Monitoring System Sales Market Share by Manufacturers (2018-2023)
2.2 Global Non-Invasive Blood Glucose Monitoring System Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Non-Invasive Blood Glucose Monitoring System Average Price by Manufacturers (2018-2023)
2.4 Global Non-Invasive Blood Glucose Monitoring System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Non-Invasive Blood Glucose Monitoring System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Invasive Blood Glucose Monitoring System, Product Type & Application
2.7 Non-Invasive Blood Glucose Monitoring System Market Competitive Situation and Trends
2.7.1 Non-Invasive Blood Glucose Monitoring System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-Invasive Blood Glucose Monitoring System Players Market Share by Revenue
2.7.3 Global Non-Invasive Blood Glucose Monitoring System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Invasive Blood Glucose Monitoring System Retrospective Market Scenario by Region
3.1 Global Non-Invasive Blood Glucose Monitoring System Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non-Invasive Blood Glucose Monitoring System Global Non-Invasive Blood Glucose Monitoring System Sales by Region: 2018-2029
3.2.1 Global Non-Invasive Blood Glucose Monitoring System Sales by Region: 2018-2023
3.2.2 Global Non-Invasive Blood Glucose Monitoring System Sales by Region: 2024-2029
3.3 Global Non-Invasive Blood Glucose Monitoring System Global Non-Invasive Blood Glucose Monitoring System Revenue by Region: 2018-2029
3.3.1 Global Non-Invasive Blood Glucose Monitoring System Revenue by Region: 2018-2023
3.3.2 Global Non-Invasive Blood Glucose Monitoring System Revenue by Region: 2024-2029
3.4 North America Non-Invasive Blood Glucose Monitoring System Market Facts & Figures by Country
3.4.1 North America Non-Invasive Blood Glucose Monitoring System Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non-Invasive Blood Glucose Monitoring System Sales by Country (2018-2029)
3.4.3 North America Non-Invasive Blood Glucose Monitoring System Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Invasive Blood Glucose Monitoring System Market Facts & Figures by Country
3.5.1 Europe Non-Invasive Blood Glucose Monitoring System Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non-Invasive Blood Glucose Monitoring System Sales by Country (2018-2029)
3.5.3 Europe Non-Invasive Blood Glucose Monitoring System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Invasive Blood Glucose Monitoring System Market Facts & Figures by Country
3.6.1 Asia Pacific Non-Invasive Blood Glucose Monitoring System Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non-Invasive Blood Glucose Monitoring System Sales by Country (2018-2029)
3.6.3 Asia Pacific Non-Invasive Blood Glucose Monitoring System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-Invasive Blood Glucose Monitoring System Market Facts & Figures by Country
3.7.1 Latin America Non-Invasive Blood Glucose Monitoring System Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non-Invasive Blood Glucose Monitoring System Sales by Country (2018-2029)
3.7.3 Latin America Non-Invasive Blood Glucose Monitoring System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Invasive Blood Glucose Monitoring System Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Invasive Blood Glucose Monitoring System Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non-Invasive Blood Glucose Monitoring System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non-Invasive Blood Glucose Monitoring System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Invasive Blood Glucose Monitoring System Sales by Type (2018-2029)
4.1.1 Global Non-Invasive Blood Glucose Monitoring System Sales by Type (2018-2023)
4.1.2 Global Non-Invasive Blood Glucose Monitoring System Sales by Type (2024-2029)
4.1.3 Global Non-Invasive Blood Glucose Monitoring System Sales Market Share by Type (2018-2029)
4.2 Global Non-Invasive Blood Glucose Monitoring System Revenue by Type (2018-2029)
4.2.1 Global Non-Invasive Blood Glucose Monitoring System Revenue by Type (2018-2023)
4.2.2 Global Non-Invasive Blood Glucose Monitoring System Revenue by Type (2024-2029)
4.2.3 Global Non-Invasive Blood Glucose Monitoring System Revenue Market Share by Type (2018-2029)
4.3 Global Non-Invasive Blood Glucose Monitoring System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Non-Invasive Blood Glucose Monitoring System Sales by Application (2018-2029)
5.1.1 Global Non-Invasive Blood Glucose Monitoring System Sales by Application (2018-2023)
5.1.2 Global Non-Invasive Blood Glucose Monitoring System Sales by Application (2024-2029)
5.1.3 Global Non-Invasive Blood Glucose Monitoring System Sales Market Share by Application (2018-2029)
5.2 Global Non-Invasive Blood Glucose Monitoring System Revenue by Application (2018-2029)
5.2.1 Global Non-Invasive Blood Glucose Monitoring System Revenue by Application (2018-2023)
5.2.2 Global Non-Invasive Blood Glucose Monitoring System Revenue by Application (2024-2029)
5.2.3 Global Non-Invasive Blood Glucose Monitoring System Revenue Market Share by Application (2018-2029)
5.3 Global Non-Invasive Blood Glucose Monitoring System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Laboratories Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Medtronic plc
6.2.1 Medtronic plc Corporation Information
6.2.2 Medtronic plc Description and Business Overview
6.2.3 Medtronic plc Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Medtronic plc Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.2.5 Medtronic plc Recent Developments/Updates
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.3.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.3.3 F. Hoffmann-La Roche Ltd. Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 F. Hoffmann-La Roche Ltd. Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.3.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.4 Ascensia Diabetes Care
6.4.1 Ascensia Diabetes Care Corporation Information
6.4.2 Ascensia Diabetes Care Description and Business Overview
6.4.3 Ascensia Diabetes Care Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ascensia Diabetes Care Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.4.5 Ascensia Diabetes Care Recent Developments/Updates
6.5 Dexcom, Inc.
6.5.1 Dexcom, Inc. Corporation Information
6.5.2 Dexcom, Inc. Description and Business Overview
6.5.3 Dexcom, Inc. Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Dexcom, Inc. Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.5.5 Dexcom, Inc. Recent Developments/Updates
6.6 Sanofi Novo Nordisk
6.6.1 Sanofi Novo Nordisk Corporation Information
6.6.2 Sanofi Novo Nordisk Description and Business Overview
6.6.3 Sanofi Novo Nordisk Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sanofi Novo Nordisk Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.6.5 Sanofi Novo Nordisk Recent Developments/Updates
6.7 Insulet Corporation
6.6.1 Insulet Corporation Corporation Information
6.6.2 Insulet Corporation Description and Business Overview
6.6.3 Insulet Corporation Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Insulet Corporation Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.7.5 Insulet Corporation Recent Developments/Updates
6.8 Ypsomed Holdings
6.8.1 Ypsomed Holdings Corporation Information
6.8.2 Ypsomed Holdings Description and Business Overview
6.8.3 Ypsomed Holdings Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Ypsomed Holdings Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.8.5 Ypsomed Holdings Recent Developments/Updates
6.9 Glysens Incorporated
6.9.1 Glysens Incorporated Corporation Information
6.9.2 Glysens Incorporated Description and Business Overview
6.9.3 Glysens Incorporated Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Glysens Incorporated Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.9.5 Glysens Incorporated Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Invasive Blood Glucose Monitoring System Industry Chain Analysis
7.2 Non-Invasive Blood Glucose Monitoring System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Invasive Blood Glucose Monitoring System Production Mode & Process
7.4 Non-Invasive Blood Glucose Monitoring System Sales and Marketing
7.4.1 Non-Invasive Blood Glucose Monitoring System Sales Channels
7.4.2 Non-Invasive Blood Glucose Monitoring System Distributors
7.5 Non-Invasive Blood Glucose Monitoring System Customers
8 Non-Invasive Blood Glucose Monitoring System Market Dynamics
8.1 Non-Invasive Blood Glucose Monitoring System Industry Trends
8.2 Non-Invasive Blood Glucose Monitoring System Market Drivers
8.3 Non-Invasive Blood Glucose Monitoring System Market Challenges
8.4 Non-Invasive Blood Glucose Monitoring System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
